Kacena MA, Chou ST, Weiss MJ, Raskind WH. GATA1-related x-linked cytopenia. In: Pagon RA, Bird TD, Dolan CR, et al, eds. GeneReviewsTM [internet]. Seattle, WA: University of Washington, Seattle; 1993. http://www.ncbi.nlm.nih.gov/books/NBK1364/. Published November 22, 2006. Revised March 22, 2011. Accessed May 30, 2012.
Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII deficiency. Semin Thromb Hemost. 2009;35(4):426-438.
Kessler CM, Acs P, Mariani G. Acquired disorders of coagulation: the immune coagulopathies. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:1061-1084.
Kessler CM, Khokhar N, Liu M. A systematic approach to the bleeding patient: correlation of clinical symptoms and signs with laboratory testing. In: Kitchens CS, Alving BM, Kessler CM, eds. Consultative Hemostasis and Thrombosis. 2nd ed. Philadelphia, PA: Saunders Elsevier; 2007:17-33.
Kim H-H, Liao JK. Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol. 2008;28(8):s39-s42.
King JAC, Elkhalifa MY, Latour LF. Rapid progression of acquired amegakaryocytic thrombocytopenia to aplastic anemia. South Med J. 1997;90(1):91-94.
Kitchens CS. Surgery and hemostasis. In: Kitchens CS, Alving BM, Kessler CM, eds. Consultative Hemostasis and Thrombosis. 2nd ed. Philadelphia, PA: Saunders Elsevier; 2007:613-634.
Kohler HP, Ichinose A, Seitz R, Ariens RAS, Muszbek L; Factor XIII and Fibrinogen SSC Subcommittee of the ISTH. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost. 2011;9(7):1404-1406.
Konkle BA. Clinical approach to the bleeding patient. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:1147-1158.
Kottke-Marchant K. Platelet disorders. In: Kottke-Marchant K, ed. An Algorithmic Approach to Hemostasis Testing. Northfield, IL: College of American Pathologists; 2008:185-216.
Kottke-Marchant K. Platelet testing. In: Kottke-Marchant K, ed. An Algorithmic Approach to Hemostasis Testing. Northfield, IL: College of American Pathologists; 2008:93-112.
Kubitza D, Becka M, Mueck W, Zuehlsdorf M. Rivaroxaban (BAY 59-7939)—an oral, direct factor Xa inhibitor—has no clinically relevant interaction with naproxen. Br J Clin Pharmacol. 2007;63(4):469-476.
Kumar V, Abbas AK, Fausto N, Aster JC, eds. Diseases of white blood cells, lymph nodes, spleen, and thymus. In: Kumar V, Abbas AK, Fausto N, Aster JC, eds. Robbins and Cotran Pathologic Basis of Disease, Professional Edition. 8th ed. Philadelphia, PA: Saunders Elsevier; 2010.
Kuter DJ. General aspects of thrombocytopenia, platelet transfusions, and thrombopoietic growth factors. In: Kitchens CS, Alving BM, Kessler CM, eds. Consultative Hemostasis and Thrombosis. 2nd ed. Philadelphia, PA: Saunders Elsevier; 2007:111-122.